
This study involved 320 cancer patients from four Northern European zzso Patients with breakthrough pain were questioned about the characteristics of their pain, the current management of their pain, and the zzso of alternative routes of zzso The median number of episodes was zzso zzso percent patients reported zzso pain, zzso zzso pain, and zzso a combination of these zzso The median duration was 60 zzso and the median time to peak intensity was 15 zzso Three percent patients reported zzso pain, 37% zzso pain, and zzso zzso zzso zzso percent patients stated that the pain zzso with their daily zzso All patients were using zzso as rescue medication zzso oral zzso whilst zzso patients were using zzso and 50% patients were using zzso zzso Only zzso patients took rescue medication every time they experienced breakthrough zzso zzso percent patients would definitely consider using an oral zzso zzso patients from Denmark were less likely to answer zzso and a positive response was associated with previous use of the route for breakthrough zzso zzso percent patients reported regular oral zzso zzso percent patients would definitely consider using an zzso product, with zzso patients stating they would definitely not use such a zzso patients from Denmark and Sweden were less likely to answer zzso and a positive response was associated with male zzso and previous use of the zzso zzso percent patients reported regular zzso zzso Sixty percent patients would definitely consider using a subcutaneous product, and zzso patients would definitely consider using an zzso zzso 

